Cite
HARVARD Citation
Klink, A. et al. (2022). Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia. Leukemia research. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Klink, A. et al. (2022). Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia. Leukemia research. p. . [Online].